Sarah L. Buchan

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 701 citations · Full text

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Sarah L. Buchan, Lang Dou, Marcus Remer et al. · Immunity · 2018 · 145 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Allergy +9

PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough et al. · Clinical Cancer Research · 2018 · 107 citations · Full text

Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen

Sarah L. Buchan, Eirik Grønevik, Iacob Mathiesen et al. · The Journal of Immunology · 2005 · 102 citations

Immunology, Immunoediting, Cd4 T Cell Responses +18

DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines

Jason Rice, Tim Elliott, Sarah L. Buchan et al. · The Journal of Immunology · 2001 · 95 citations · Full text